Literature DB >> 24981300

Usefulness of snoreplasty in the treatment of simple snoring and mild obstructive sleep apnea/hypopnea syndrome - Preliminary report.

Ewa Olszewska1, Justyna Panek2, John O'Day3, Marek Rogowski2.   

Abstract

THE AIM OF THE STUDY: To assess the effectiveness of sodium tetradecyl sulfate injection in the region of the soft palate to treat primary snoring and mild obstructive sleep apnea/hypopnea syndrome. Sodium tetradecyl sulfate, a preparation belonging to detergents, widely applied in Poland to treat varices by the method of compressive sclerotherapy was used in the study.
MATERIAL AND METHODS: The procedure of injected snoreplasty was performed in 21 patients, who were diagnosed with primary snoring or mild obstructive sleep apnea/hypopnea syndrome, based on subjective examination and polysomnography. Injected snoreplasty involves administration of sodium tetradecyl sulfate in the form of Fibrovein 1% or 3% preparation in the volume of 2ml, in the region of the soft palate. Injection of the preparation in the area of the soft palate induces the development of aseptic inflammation, which creates a scar which stiffens the soft palate and makes the tissues of this region less susceptible to vibrations.
RESULTS: The patients after injected snoreplasty reported a significant decrease in the intensity of snoring. The markedly shortened total time of snoring was found in check-up polysomnography performed six months after the procedure.
CONCLUSIONS: Injected snoreplasty is an effective procedure, especially, in patients manifesting persistent snoring. It is not indicated in the treatment of obstructive apneas during sleep. The advantages of this method are: minimal invasiveness, the low number of complications and slight pain.
Copyright © 2013 Polish Otorhinolaryngology - Head and Neck Surgery Society. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.

Entities:  

Keywords:  Primary snoring; Sleep apnea; Snoreplasty; Sodium tetradecyl sulfate; bezdech senny; chrapanie pierwotne; siarczan sodowy tetradecylu; snoreplastyka

Mesh:

Substances:

Year:  2013        PMID: 24981300     DOI: 10.1016/j.otpol.2013.07.005

Source DB:  PubMed          Journal:  Otolaryngol Pol        ISSN: 0030-6657


  1 in total

1.  Outpatient erbium:YAG (2940 nm) laser treatment for snoring: a prospective study on 40 patients.

Authors:  Isabelle Fini Storchi; Steven Parker; Francesca Bovis; Stefano Benedicenti; Andrea Amaroli
Journal:  Lasers Med Sci       Date:  2018-01-15       Impact factor: 3.161

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.